Phase 4 Alzheimer's Disease Trial, Not Yet Recruiting NCT03454646 Sponsor: University Hospital, Bordeaux Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 4 Alzheimer's Disease Trial, Not Yet Recruiting

NCT03454646
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been newly diagnosed with Alzheimer's disease (AD) and have been referred to a specialist memory centre.
  • People who have a diagnosis of probable or possible Alzheimer's disease, based on recognised medical diagnostic guidelines.
  • People whose Alzheimer's disease is at a mild to moderate stage, shown by a memory and thinking test score above 15 at the time of initial assessment.
  • People for whom a cholinesterase inhibitor (a common type of Alzheimer's medication) has been recommended by their doctor.
  • People who have not previously taken a cholinesterase inhibitor medication.
  • People aged 50 years or older.
  • Women who have gone through menopause or who are using effective contraception.
  • People who are members of, or covered by, a social security scheme.
  • People who have official long-term illness status for Alzheimer's disease.
  • People who agree to take part, and who have given free, informed, and written consent, along with their caregiver.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have responded well to cholinesterase inhibitor treatment, meaning their memory and thinking test score stayed the same or improved after 6 months of treatment.
  • People who are fully dependent on others for bathing and dressing at the time of the randomisation visit.
  • People who are living in a care facility or institution at the time of the randomisation visit.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 05 57 82 01 16

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
27 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The primary outcome is a combination of complete BADL dependency in bathing and dressing and/or institutionalization or death at 2 years after randomization.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov